Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline. So what: If you purchased Skye securities during the Class Period you […]
Las Vegas, NV, Jan. 11, 2026 (GLOBE NEWSWIRE) — At CES 2026, Speediance introduced a fully immersive smart home gym experience that allowed attendees to step directly into the future of fitness. From January 6-9 at Booth #55339, visitors were invited not just to view technology, but to experience how intelligent training, wellness, and design
(NASDAQ:KRYS), Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth PITTSBURGH, Jan. 11, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced selected preliminary unaudited 2025 financial results, including fourth quarter and full year
Speediance Brings the Future of Smart Home Fitness to Life at CES 2026 Immersive CES experience designed and executed by Cymatics Digital turns AI-powered training into a walk-in reality GlobeNewswire January 11, 2026 Las Vegas, NV, Jan. 11, 2026 (GLOBE NEWSWIRE) — At CES 2026, Speediance introduced a fully immersive smart home gym experience that
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 11, 2026 Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth PITTSBURGH, Jan. 11, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ:
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America’s Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America’s Car-Mart may have issued materially misleading business information to the investing public. So What: If you purchased America’s Car-Mart securities you may be entitled
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of National Grid plc (NYSE: NGG) resulting from allegations that National Grid plc may have issued materially misleading business information to the investing public. So What: If you purchased National Grid securities you may be
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Fermi to Contact Him Directly to Discuss Their Options If you purchased or otherwise acquired securities in Fermi (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of key corporate objectives for 2026. The company will review these updates during its presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 3:45pm PST. “2025 was a year of execution,
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2025. Preliminary, Unaudited Select Fourth Quarter 2025 Financial Results — Revenue of approximately $166.0 million for the three months ended December 31, 2025, representing 11% growth